In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma
{{output}}
Chimeric antigen receptor (CAR) T cells are highly effective in haematological malignancies1. However, progressive loss of CAR T cells contributes to relapse in many patients2-4. Here we performed in vivo loss-of-function CRISPR screens in CAR T cells targetin... ...
